Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

被引:130
作者
Dial, Sandra [1 ,2 ]
Kezouh, Abbas [4 ]
Dascal, Andre [2 ,3 ]
Barkun, Alan [1 ,5 ,6 ]
Suissa, Samy [2 ,4 ]
机构
[1] McGill Univ, Dept Med, Montreal Chest Inst, Montreal, PQ H2X 2P4, Canada
[2] McGill Univ, Dept Med, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H2X 2P4, Canada
[3] McGill Univ, Div Infect Dis, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H2X 2P4, Canada
[4] McGill Univ, Ctr Clin Epidemiol, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H2X 2P4, Canada
[5] McGill Univ, Ctr Hlth, Div Gastroenterol, Montreal, PQ H2X 2P4, Canada
[6] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H2X 2P4, Canada
关键词
D O I
10.1503/cmaj.071812
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous observations have indicated that infection with Clostridium difficile occurs almost exclusively after exposure to antibiotics, but more recent observations have suggested that prior antibiotic exposure may be less frequent among cases of community-acquired disease. Methods: We used 2 linked health databases to perform a matched, nested case-control study of elderly patients admitted to hospital with community-acquired C. difficile infection. For each of 836 cases among people 65 years of age or older, we selected 10 controls. We determined the proportion of cases that occurred without prior antibiotic exposure and estimated the risk related to exposure to different antibiotics and the duration of increased risk. Results: Of the 836 cases, 442 (52.9%) had no exposure to antibiotics in the 45-day period before the index date, and 382 (45.7%) had no exposure in the 90-day period before the index date. Antibiotic exposure was associated with a rate ratio (RR) of 10.6 (95% confidence interval [CI] 8.9-12.8). Clindamycin (RR 31.8, 95% CI 17.6-57.6), cephalosporins (RR 14.9, 95% CI 10.9-20.3) and gatifloxacin (RR 16.7, 95% CI 8.3-33.6) were associated with the highest risk. The RR for C. difficile infection associated with antibiotic exposure declined from 15.4 (95% CI 12.2-19.3) by about 20 days after exposure to 3.2 (95% CI 2.0-5.0) after 45 days. Use of a proton pump inhibitor was associated with increased risk (RR 1.6, 95% CI 1.3-2.0), as were concurrent diagnoses of inflammatory bowel disease (RR 4.1, 95% CI 2.6-6.6), irritable bowel syndrome (RR 3.4, 95% CI 2.3-5.0) and renal failure (RR 1.7, 95% CI 1.2-2.2). Interpretation: Community-acquired C. difficile infection occurred in a substantial proportion of individuals with no recent exposure to antibiotics. Among patients who had been exposed to antibiotics, the risk declined markedly by 45 days after discontinuation of use.
引用
收藏
页码:767 / 772
页数:6
相关论文
共 28 条
  • [1] BARTLETT JG, 1981, JOHNS HOPKINS MED J, V149, P6
  • [2] ANTIBIOTIC-ASSOCIATED DIARRHEA
    BARTLETT, JG
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (04) : 573 - 581
  • [3] Historical perspectives on studies of Clostridium difficile and C difficile infection
    Bartlett, John G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 : S4 - S11
  • [4] Narrative review: The new epidemic of clostridium difficile-associated enteric disease
    Bartlett, John G.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (10) : 758 - 764
  • [5] The challenges posed by reemerging Clostridium difficile infection
    Blossom, David B.
    McDonald, L. Clifford
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (02) : 222 - 227
  • [6] Hospital-wide restriction of clindamycin:: Effect on the incidence of Clostridium difficile-associated diarrhea and cost
    Climo, MW
    Israel, DS
    Wong, ES
    Williams, D
    Coudron, P
    Markowitz, SM
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (12) : 989 - +
  • [7] Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease -: Reply
    Dial, S
    Delaney, JAC
    Barkun, AN
    Suissa, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (22): : 2600 - 2601
  • [8] Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
    Dial, S
    Delaney, JAC
    Barkun, AN
    Suissa, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23): : 2989 - 2995
  • [9] Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy
    Dial, Sandra
    Delaney, J. A. Chris
    Schneider, Verena
    Suissa, Samy
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (07) : 745 - 748
  • [10] ICD-9 codes and surveillance for Clostridium difficile-associated disease
    Dubberke, Erik R.
    Reske, Kimberly A.
    McDonald, L. Clifford
    Fraser, Victoria J.
    [J]. EMERGING INFECTIOUS DISEASES, 2006, 12 (10) : 1576 - 1579